FDA Inspection 1237013 — Estee Lauder N.V.

Estee Lauder N.V. — FEI 1000224360

The FDA completed an inspection of Estee Lauder N.V. on April 26, 2024 in Oevel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oevel (Belgium)

Citations

IDCFRDescription
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs